These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 28501509)

  • 1. Designer outer membrane vesicles as immunomodulatory systems - Reprogramming bacteria for vaccine delivery.
    Gnopo YMD; Watkins HC; Stevenson TC; DeLisa MP; Putnam D
    Adv Drug Deliv Rev; 2017 May; 114():132-142. PubMed ID: 28501509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.
    Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H
    Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of foreign antigens by engineered outer membrane vesicle vaccines.
    Chen DJ; Osterrieder N; Metzger SM; Buckles E; Doody AM; DeLisa MP; Putnam D
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3099-104. PubMed ID: 20133740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioengineering bacterial outer membrane vesicles as vaccine platform.
    Gerritzen MJH; Martens DE; Wijffels RH; van der Pol L; Stork M
    Biotechnol Adv; 2017 Sep; 35(5):565-574. PubMed ID: 28522212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor.
    Wang S; Huang W; Li K; Yao Y; Yang X; Bai H; Sun W; Liu C; Ma Y
    Int J Nanomedicine; 2017; 12():6813-6825. PubMed ID: 28979120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial-Derived Outer Membrane Vesicles are Potent Adjuvants that Drive Humoral and Cellular Immune Responses.
    Prior JT; Davitt C; Kurtz J; Gellings P; McLachlan JB; Morici LA
    Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33498352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles.
    Salverda ML; Meinderts SM; Hamstra HJ; Wagemakers A; Hovius JW; van der Ark A; Stork M; van der Ley P
    Vaccine; 2016 Feb; 34(8):1025-33. PubMed ID: 26801064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial outer membrane vesicle-based cancer nanovaccines.
    Gao X; Feng Q; Wang J; Zhao X
    Cancer Biol Med; 2022 Sep; 19(9):1290-300. PubMed ID: 36172794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of outer membrane vesicles of periodontopathic bacterium Porphyromonas gingivalis as possible mucosal immunogen.
    Nakao R; Hasegawa H; Dongying B; Ohnishi M; Senpuku H
    Vaccine; 2016 Aug; 34(38):4626-4634. PubMed ID: 27461458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
    Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
    Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis.
    Gerritzen MJH; Maas RHW; van den Ijssel J; van Keulen L; Martens DE; Wijffels RH; Stork M
    Microb Cell Fact; 2018 Oct; 17(1):157. PubMed ID: 30285743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in various bio-applications of bacteria-derived outer membrane vesicles.
    Sadeghi L; Mohit E; Moallemi S; Ahmadi FM; Bolhassani A
    Microb Pathog; 2023 Dec; 185():106440. PubMed ID: 37931826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of
    Croia L; Boscato Sopetto G; Zanella I; Caproni E; Gagliardi A; Tamburini S; König E; Benedet M; Di Lascio G; Corbellari R; Grandi A; Tomasi M; Grandi G
    Membranes (Basel); 2023 Nov; 13(11):. PubMed ID: 37999368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with outer membrane vesicles and the fimbrial protein FlfA offers improved protection against lesions following challenge with Gallibacterium anatis.
    Persson G; Pors SE; Thøfner ICN; Bojesen AM
    Vet Microbiol; 2018 Apr; 217():104-111. PubMed ID: 29615242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A basis for vaccine development: Comparative characterization of Haemophilus influenzae outer membrane vesicles.
    Roier S; Blume T; Klug L; Wagner GE; Elhenawy W; Zangger K; Prassl R; Reidl J; Daum G; Feldman MF; Schild S
    Int J Med Microbiol; 2015 May; 305(3):298-309. PubMed ID: 25592265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer Membrane Vesicles: An Emerging Vaccine Platform.
    Kashyap D; Panda M; Baral B; Varshney N; R S; Bhandari V; Parmar HS; Prasad A; Jha HC
    Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice.
    Rappazzo CG; Watkins HC; Guarino CM; Chau A; Lopez JL; DeLisa MP; Leifer CA; Whittaker GR; Putnam D
    Vaccine; 2016 Mar; 34(10):1252-8. PubMed ID: 26827663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.
    Huang W; Wang S; Yao Y; Xia Y; Yang X; Li K; Sun P; Liu C; Sun W; Bai H; Chu X; Li Y; Ma Y
    Sci Rep; 2016 Nov; 6():37242. PubMed ID: 27849050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outer membrane vesicle: a macromolecule with multifunctional activity.
    Moshiri A; Dashtbani-Roozbehani A; Najar Peerayeh S; Siadat SD
    Hum Vaccin Immunother; 2012 Jul; 8(7):953-5. PubMed ID: 22699443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of microbiota derived outer membrane vesicles to preventive, therapeutic and diagnostic proposes.
    Jalalifar S; Morovati Khamsi H; Hosseini-Fard SR; Karampoor S; Bajelan B; Irajian G; Mirzaei R
    Infect Agent Cancer; 2023 Jan; 18(1):3. PubMed ID: 36658631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.